190 related articles for article (PubMed ID: 20510890)
1. Distribution of 5-HT1B and 5-HT1D receptors in the inner ear.
Ahn SK; Balaban CD
Brain Res; 2010 Jul; 1346():92-101. PubMed ID: 20510890
[TBL] [Abstract][Full Text] [Related]
2. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
Classey JD; Bartsch T; Goadsby PJ
Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
[TBL] [Abstract][Full Text] [Related]
3. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT
Edvinsson JCA; Maddahi A; Christiansen IM; Reducha PV; Warfvinge K; Sheykhzade M; Edvinsson L; Haanes KA
J Headache Pain; 2022 Feb; 23(1):26. PubMed ID: 35177004
[TBL] [Abstract][Full Text] [Related]
4. 5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache.
Ivanusic JJ; Kwok MMK; Ahn AH; Jennings EA
Headache; 2011 Mar; 51(3):392-402. PubMed ID: 21352213
[TBL] [Abstract][Full Text] [Related]
5. 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase.
Hou M; Kanje M; Longmore J; Tajti J; Uddman R; Edvinsson L
Brain Res; 2001 Aug; 909(1-2):112-20. PubMed ID: 11478927
[TBL] [Abstract][Full Text] [Related]
6. Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats.
Ma QP
Neuroreport; 2001 Jun; 12(8):1589-91. PubMed ID: 11409721
[TBL] [Abstract][Full Text] [Related]
7. Targeting the 5-HT
Huang PC; Yang FC; Chang CM; Yang CP
Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517
[TBL] [Abstract][Full Text] [Related]
8. Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input.
Jeggo RD; Wang Y; Jordan D; Ramage AG
Br J Pharmacol; 2007 Apr; 150(8):987-95. PubMed ID: 17339842
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system.
Amrutkar DV; Ploug KB; Hay-Schmidt A; Porreca F; Olesen J; Jansen-Olesen I
Pain; 2012 Apr; 153(4):830-838. PubMed ID: 22305629
[TBL] [Abstract][Full Text] [Related]
10. Expression of transient receptor potential vanilloid (TRPV) 1, 2, 3, and 4 in mouse inner ear.
Ishibashi T; Takumida M; Akagi N; Hirakawa K; Anniko M
Acta Otolaryngol; 2008; 128(12):1286-93. PubMed ID: 18607942
[TBL] [Abstract][Full Text] [Related]
11. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception.
Bartsch T; Knight YE; Goadsby PJ
Ann Neurol; 2004 Sep; 56(3):371-81. PubMed ID: 15349864
[TBL] [Abstract][Full Text] [Related]
12. Marked sexual dimorphism in 5-HT
Araldi D; Ferrari LF; Green P; Levine JD
Neuroscience; 2017 Mar; 344():394-405. PubMed ID: 28040566
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
Ma QP; Hill R; Sirinathsinghji D
Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450
[TBL] [Abstract][Full Text] [Related]
14. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Kayser V; Aubel B; Hamon M; Bourgoin S
Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
[TBL] [Abstract][Full Text] [Related]
15. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.
Donaldson C; Boers PM; Hoskin KL; Zagami AS; Lambert GA
Neuropharmacology; 2002 Mar; 42(3):374-85. PubMed ID: 11897116
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
17. Serotonin type-1D receptor stimulation of A-type K(+) channel decreases membrane excitability through the protein kinase A- and B-Raf-dependent p38 MAPK pathways in mouse trigeminal ganglion neurons.
Zhao X; Zhang Y; Qin W; Cao J; Zhang Y; Ni J; Sun Y; Jiang X; Tao J
Cell Signal; 2016 Aug; 28(8):979-88. PubMed ID: 27156838
[TBL] [Abstract][Full Text] [Related]
18. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Muñoz-Islas E; Gupta S; Jiménez-Mena LR; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
Br J Pharmacol; 2006 Sep; 149(1):82-91. PubMed ID: 16880765
[TBL] [Abstract][Full Text] [Related]
19. Chiral aryloxyalkylamines: Selective 5-HT(1B/1D) activation and analgesic activity.
Carocci A; Lentini G; Catalano A; Cavalluzzi MM; Bruno C; Muraglia M; Colabufo NA; Galeotti N; Corbo F; Matucci R; Ghelardini C; Franchini C
ChemMedChem; 2010 May; 5(5):696-704. PubMed ID: 20235265
[TBL] [Abstract][Full Text] [Related]
20. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input.
Goadsby PJ; Classey JD
Neuroscience; 2003; 122(2):491-8. PubMed ID: 14614913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
